-
ISABEL VELLOSO
Madrid
-
JAVIER MUNERA
Madrid
–
The vaccineby Pfizer for children between the ages of five and 12, such as the one that has begun to be used in the US, generates more antibodies than the one that has been inoculated to millions of adults around the world